GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » Short Interest

Braxia Scientific (XCNQ:BRAX) Short Interest


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Braxia Scientific's Short Interest

For the Biotechnology subindustry, Braxia Scientific's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Braxia Scientific's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braxia Scientific's Short Interest distribution charts can be found below:

* The bar in red indicates where Braxia Scientific's Short Interest falls into.


Braxia Scientific (XCNQ:BRAX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » Short Interest
Comparable Companies
XCNQ:MBIO XCNQ:NOVA TSX:APLI TSXV:IOT XCNQ:MESC XCNQ:BIOV XCNQ:GLOW TSXV:RP TSXV:MRVL TSX:IPCI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
BRAXF:USA 4960:Germany
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Website
https://www.braxiascientific.com
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (XCNQ:BRAX) Headlines

No Headlines